Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
PaxVax, Inc.
3114
PaxVax, Inc.
Technology
Biotechnology
PaxVax is a start-up developing candidate oral vaccines for key infectiousdiseases, including influenza.
Suggest edits
Founded
2007
Raised
$185M
Follow us
Also headquartered in Menlo Park
Facebook
Andreessen Horowitz
Sequoia Capital
Kleiner Perkins
Silver Lake
NEA
Lightspeed Venture Partners
Parse
Mayfield
Lucid Motors
Companies in the same industry
Blaze Bioscience
Akebia Therapeutics
Thermalin Diabetes, LLC
zappylab
Oceana Therapeutics
Immune Targeting Systems
Aduro BioTech
Synageva BioPharma Corp.
ChronixBiomedical
Reata Pharmaceuticals
Alexa global traffic share
Overview
Funding
5
Add info
Latest funding
Show all
$105,000,000
Private equity - 2015
Cerberus Capital Management
$50,000,000
Debt financing - 2014
Pharmakon Advisors
Team Size
50+
Employees
I work here
Location
Menlo Park
,
United States
Headquarters
Explore Menlo Park
FinSMEs
Emergent BioSolutions to Acquire Vaccines Company PaxVax, for $270M
Health
$105,000,000
Private equity
VentureWire
The Daily Startup: Vaccine Maker PaxVax Picks Up $105 Million
Funding
